Nordic Register and Biobank Data
|
|
- Judith Phelps
- 6 years ago
- Views:
Transcription
1 Nordic Register and Biobank Data A basis for innovative research on health and welfare Juni Palmgren Karolinska Institutet, Stockholm Nordic conference on Real World Data Helsinki November 2016
2 Nordic populations 5,5M 0,3M 9,3M 5,3M 4,9M J Palmgren 2
3 Nordic population based registries LIFE SPAN REGISTRIES EARLY LIFE Cancer Hospital Discharge LATE LIFE Birth Congenital Malformations Clinical Quality Registries Specific Disease Registries Register of prescribed drug sales Cause of Death L I F E GENETICALLY INFORMATIVE Population Multiple Generation Twin Migration 3
4 The biobank perspective Genomes (Sanger, EBI + NCBI) Nucleotide sequence EMBL-Bank+Genbank+DDBj Gene expression ArrayExpress, GEO Protein families, motifs and domains InterPro (12 collaborators) Protein interactions IntAct with Imex, PRIDE Pathways Kegg; Reactome Protein sequence UniProt(EBI/SIB/PIR) Protein structure wwpdb(rcsb,ebi,pdbj) Chemical entities ChEBI; PubChem From molecules to systems Systems BioModels From Janet Thornton, EBI
5 A longitudinal perspective on health and disease Personalized diagnostics and treatment Cured Healthy Diagnosis Chronic/current disease Dead time 12 december
6 Type 2 Diabetes > individuals National Biobanks Finland portal individuals from population cohorts individuals from disease collections Cardiovascular events stroke, CHD individuals Life course events High Blood pressure Cardiovascular risk factor data individuals REGISTROMICS Severe mental health: Social security number Cause of death data - schizophrenia, depression - > 5000 individuals Prescription medication data Migraine individuals National Biobank individuals statin users estrogen substitution th Old age dementia, ~ 5000 individuals Cancer > cases Life style and socio-economic data - education, economic state, smoking
7 Data integration and interoperability? Fantastic opportunities! Obstacles: Many data owners Multitude of regulations and practices Weak documentation, metadata, ontologies Secure sharing? Norden? Tedious and complicated within countries more so between countries J Palmgren 7
8 Nordic research data Nordic Council of Ministers (NCM) Marie Sandberg, CSC, 2012 Challenges from six perspectives: The political perspective The organizational perspective The legal perspective The financial perspective The ethical perspective The technical perspective The lack of a Nordic perspective for research data implies a risk of developing policy directives which are not aligned on the Nordic level.
9 A vision A Nordic Commons A shared virtual space where scientists can work with the digital objects of biomedical research. This is a system that will allow investigators to find, manage, share, use and reuse data, software, metadata and workflows. From Data Science at NIH
10 Components of a Commons ecosystem from A computing environment, such as the cloud and/or HPC (High Performance Computing) resources, which support access, utilization and storage of digital objects. Data sets that adhere to a set of Digital Object Compliance Principles which describe the properties of digital objects that enables them to be findable, accessible, interoperable and reproducible (FAIR). Software services and tools that enable; Scalable provisioning of compute resources. Interoperability between digital objects within the Commons. Indexing and thus discoverability of digital objects. Sharing of digital objects between individuals or groups. Access to and deployment of scientific analysis tools and pipeline workflows. Connectivity with other repositories, registries and resources that support scholarly research.
11 A Nordic context (Common pot initiative) The NordForsk Programme on Health and Welfare Academy of Finland, Danish Research Council for Independent Research/Medical Sciences, Icelandic Centre of Research (Rannis), The Research Council of Norway, The Swedish Research Council for Health, Working Life and Welfare (FORTE) The Swedish Research Council NordForsk. The Programme runs from 2014 to 2018, covers 11 research projects in The perspective is broad. From 2017 a Research Infrastructure and an education component are planned as part of the Programme
12 A Nordic Commons would rely on A clear legal and ethical framework for sharing data and tools across borders Transparency and an open access policy Involvement of a broad range of Nordic key stakeholders Political level (legislation and ethics) Research funding level National data-owner institutions escience and einfrastructure expertize Scientists The Nordic countries need to tap into the ongoing discussions on Open Science and data sharing in the contect of the EU Open Science Cloud and other international initiatives.
13 Open access to scientific information
14 J Palmgren 14
15
16 Summary Recommendations for Norden Legislation: Coordinate national legislation and legal practices in the wake of new EU GDPR. Harmonize handling of sensitive research data from registers, cohorts, biobanks and molecular data repositories Ethics: Set up a simplified and coherent ethics review process for cross-nordic studies Metadata: Create compatible meta-data models within and across Nordic data sources. Open Access: Coordinate high level demands for open access to data and methods. A Nordic Commons: Work towards an integrated system for finding, managing, sharing, using and reusing data, software, metadata and workflows
17 Sharing Mine! across organisations disciplines geographical and institutional boarders research groups and scientists Beware of financial, organisational, technical, legal, ethical, cultural obstacles 17
Nordic health data project. Magnus Eriksson, Chair of metadatagroup 28. nov 2018
Nordic health data project Magnus Eriksson, Chair of metadatagroup 28. nov 2018 Research Infrastructure for Nordic Health Data NordForsk Program on Health and Welfare Recent background: NordForsk Policy
More informationNordic Common Strengths and Future Potential in the Field of Personalised Medicine
Nordic Common Strengths and Future Potential in the Field of Personalised Medicine NOS-M Workshop 23rd November 2016 Stockholm Waterfront Johan Nilsson Coordinator Medicine and Health Swedish Research
More informationEuropean Genome phenome Archive at the European Bioinformatics Institute. Helen Parkinson Head of Molecular Archives
European Genome phenome Archive at the European Bioinformatics Institute Helen Parkinson Head of Molecular Archives What is EMBL-EBI? International, non-profit research institute Part of the European Molecular
More informationElixir: European Bioinformatics Research Infrastructure. Rolf Apweiler
Elixir: European Bioinformatics Research Infrastructure Rolf Apweiler EMBL-EBI Service Mission To enable life science research and its translation to medicine, agriculture, the bioindustries and society
More informationIntroduction to EMBL-EBI.
Introduction to EMBL-EBI www.ebi.ac.uk What is EMBL-EBI? Part of EMBL Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, the Netherlands,
More informationProfessor Ewan Birney FRS Director, EMBL-EBI
Infrastructures for research and innovation Professor Ewan Birney FRS Director, EMBL-EBI www.ebi.ac.uk Outline of talk Who Am I, What is EMBL? The change in genomics The needs for stratified patients in
More informationGlobal Biomolecular Information Infrastructure and Australia. Graham Cameron Director The EMBL Australia Bioinformatics Resource
Global Biomolecular Information Infrastructure and Australia Graham Cameron Director The EMBL Australia Bioinformatics Resource What is bioinformatics? Methods, data, IT to exploit biomolecular information
More informationElixir: Overview, Progress and Futures
Elixir: Overview, Progress and Futures 20th Meeting of the EC-US Biotechnology Task Force Barcelona 3 June 2010 Andrew Lyall, ELIXIR Project Manager www.elixir-europe.org ELIXIR: a sustainable infrastructure
More informationFinnish Biobanks. The most advanced testbed in the world
Finnish Biobanks The most advanced testbed in the world Jaana Hartikainen, Ph.D., Adjunct Professor in Molecular Genetics Assistant Professor in Translational Cancer Research and Biobank Research University
More informationInterpreting Genome Data for Personalised Medicine. Professor Dame Janet Thornton EMBL-EBI
Interpreting Genome Data for Personalised Medicine Professor Dame Janet Thornton EMBL-EBI Deciphering a genome 3 billion bases 4 million variants 21,000 coding variants 10,000 non-synonymous variants 50-100
More information~1O % of the population = 500,000 Finns
1 2 ~1O % of the population = 500,000 Finns Goals of FinnGen 3 01 03 PRODUCE MEDICAL INNOVATIONS BY COMBINING HEALTH REGISTRY AND GENOME DATA CREATE A CO-OPERATION MODEL BETWEEN PUBLIC SECTOR AND HEALTHCARE
More informationBBMRI.NL A story of Sharing Eline Slagboom Molecular Epidemiology, Leiden University Medical Center Brussel 20 Juni 2017
BBMRI.NL A story of Sharing Eline Slagboom Molecular Epidemiology, Leiden University Medical Center Brussel 20 Juni 2017 BBMRI-NL TOWARDS A NATIONAL BIOBANKING INFRASTRUCTURE Founded in 2009 as the Dutch
More informationTowards standard, accessible and reproducible Metabolomics
Towards standard, accessible and reproducible Metabolomics Reza Salek PhD Metabolism and Molecular Informatics The European Bioinformatics Institute (EMBL-EBI) Email: Reza.salek@ebi.ac.uk The 1st International
More informationFuture of the Project. BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton
Future of the Project BioMedBridges 3rd Annual General Meeting 18 February 2015, Munich Janet Thornton What were goals of BioMedBridges? GOAL 1: To provide computational data and service bridges between
More informationdixa-a data infrastructure for chemical safety Jos Kleinjans Dept of Toxicogenomics Maastricht University
dixa-a data infrastructure for chemical safety Jos Kleinjans Dept of Toxicogenomics Maastricht University Big data in toxicogenomics The amountof data in ourworldhas been exploding. And the abilityto store,
More informationThe NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England
The NHS approach to personalised medicine in respiratory disease Professor Sue Hill @CSOSue Chief Scientific Officer for England Jul 2017 Genomics is probably the biggest breakthrough in the last 50 years.
More informationAarno Palotie, M.D., Ph.D.
Aarno Palotie, M.D., Ph.D. 1 Genetics and big data The technology drives the change Need of large samples EACH GENE VARIANT HAS A SMALL EFFECT The challenge: we can write down genomes, but we don t yet
More informationHealth Analytics Current data situation and use in Norway
Health Analytics Current data situation and use in Norway Anne Torill Nordsletta, Director Health Analytics, Norwegian Centre for E-health Research @ ehealthnorway 2016 Established NORWEGIAN CENTRE FOR
More informationChristoph Bock ICPerMed First Research Workshop Milano, 26 June 2017
New Tools for Personalized Medicine *Tools = Assays, Devices, Software Christoph Bock ICPerMed First Research Workshop Milano, 26 June 2017 http://epigenomics.cemm.oeaw.ac.at http://biomedical-sequencing.at
More informationELIXIR: data for molecular biology and points of entry for marine scientists
ELIXIR: data for molecular biology and points of entry for marine scientists Guy Cochrane, EMBL-EBI EuroMarine 2018 General Assembly meeting 17-18 January 2018 www.elixir-europe.org Scales of molecular
More informationall official ACS meetings and events without the express written consent from the ACS.
248th American Chemical Society National Meeting & Exposition www.acs.org/sanfran2014 The use of any device to capture images (e.g., cameras and camera phones) or sound (e.g., tape and digital recorders)
More information1.0 Background to the organisation
1.0 Background to the organisation The National University of Ireland Galway, the Royal College of Surgeons in Ireland, University College Cork, University College Dublin and Trinity College and their
More informationSAMPLE TITLE HERE. The Seven Bridges Cloud Ecosystem: Enabling Interoperable Data Access and Analysis. Liz Williams, PhD
The Seven Bridges Cloud Ecosystem: Enabling Interoperable Data Access and Analysis SAMPLE TITLE HERE 2018 Seven Bridges Liz Williams, PhD liz.williams@sbgenomics.com sevenbridges.com The content of this
More informationBioinformatics: Present & Future from an EBI Perspective. Janet Thornton. UCL February 14 th 2012
Bioinformatics: Present & Future from an EBI Perspective Janet Thornton UCL February 14 th 2012 What is bioinformatics? The science of storing, retrieving and analysing large amounts of biological information
More informationGenomics and personalised medicine
Genomics and personalised medicine Dr Tom Fowler, Deputy Chief Scientist & Director of Public Health WHO Symposium on the Future of Digital Health Systems in the European Region February 2019 About me
More informationWorkshop 4: Data Revolution (Room Louis Armand)
Workshop 4: Data Revolution (Room Louis Armand) Moderator: Remi Salomon PhD, Vice-Chairman, AP-HP (FR) @APHP Roland Eils Data Management and Genomics Computing, Cancer Research Institute DKFZ (G) @CaptainSysBio
More informationLongitudinal Population Studies Strategy
Longitudinal Population Studies Strategy Wellcome s Longitudinal Population Studies Working Group July 2017 Executive summary Opportunity Longitudinal population studies (LPS), which include cohorts, panel
More informationNIEHS and Data Integration
NIEHS and Data Integration Where We ve Been and Where We re Going Linda Birnbaum, Ph.D., D.A.B.T., A.T.S. Director National Institute of Environmental Health Sciences National Toxicology Program Informing
More informationArto Mannermaa. Research Manager, KUH Professor of personalized medicine and Biobanking, UEF
Doctoral Programme of Clinical Research Introduction to Clinical Research, 2017 Arto Mannermaa Research Manager, KUH Professor of personalized medicine and Biobanking, UEF 040-3552752 arto.mannermaa@uef.fi
More informationINDIVIDUALIZED TREATMENT
1 INDIVIDUALIZED TREATMENT The healthcare system is under pressure: better budgetary compliance, quicker treatment, more equitable patient rights, and higher expectations from patients and relatives. These
More informationTOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS
TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER
More information-YOUR PARTNER IN RESEARCH AND DEVELOPMENT
-YOUR PARTNER IN RESEARCH AND DEVELOPMENT WHY CHOOSE NORWAY? A healthcare system with great opportunities for research....... 2 Unique and accessible health registries and biobanks........... 3 A great
More informationOpen PHACTS: Semantic interoperability for drug discovery
Open PHACTS: Semantic interoperability for drug discovery ACS National Meeting, San Diego Herman van Vlijmen 16 Mar 2016 Judith Hinton Andrew, Rock Composite 22 Artwork from The Creative Center What is
More informationSo we have a Digital repository in CSIRO now what? John Morrissey and Liam O Brien
So we have a Digital repository in CSIRO now what? John Morrissey and Liam O Brien Today s Agenda The DAP today Challenging times for building new eresearch capability Top down planning activities working
More informationThe European Health Data & Evidence Network
The European Health Data & Evidence Network What is it? Nigel Hughes EFPIA Coordinator Scientific Director, JCI Patient Data for Research, Janssen 18 th May 2018 1 All too often real world research is
More informationHuman Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987
Human Genomics, Precision Medicine, and Advancing Human Health Eric Green, M.D., Ph.D. Director, NHGRI The Human Genome Cells Nucleus Chromosome DNA Human Genome: 3 Billion Bases (letters) The Origin of
More informationmars Vision Paper !! December 2013 building the Microbial Antarctic Resource System MARS VISION PAPER
mars Vision Paper building the Microbial Antarctic Resource System December 2013 1 mars creating the Microbial Antarctic Resource System Vision Paper Alison Murray 1, Anton Van de Putte 2, Nabil Youdjou
More informationOverview of the Luxembourg biomedical and health research ecosystem FNR FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017
FNR Overview of the Luxembourg biomedical and health research ecosystem FRANK GLOD LUXCOR HEALTH EVENT MONDAY 19 JUNE 2017 Research in Luxembourg Luxembourg : a young research location Creating structures
More informationLeonardo Mariño-Ramírez, PhD NCBI / NLM / NIH. BIOL 7210 A Computational Genomics 2/18/2015
Leonardo Mariño-Ramírez, PhD NCBI / NLM / NIH BIOL 7210 A Computational Genomics 2/18/2015 The $1,000 genome is here! http://www.illumina.com/systems/hiseq-x-sequencing-system.ilmn Bioinformatics bottleneck
More informationNordic Trial Alliance Nordic Cooperation in Clinical Research
Nordic Trial Alliance Nordic Cooperation in Clinical Research Mia Bengtström Nordic Trial Alliance Background Aim to strengthen clinical research in the Nordics Objective to contribute to sustainable Nordic
More informationPowering Translational Medicine with Semantic Web technologies
Powering Translational Medicine with Semantic Web technologies Michel Dumontier, Ph.D. Associate Professor of Medicine (Biomedical Informatics) Stanford University 1 Outline reproducible science linked
More informationACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes
ACCELERATING GENOMIC ANALYSIS ON THE CLOUD Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia
More information7800/16 AFG/evt 1 DG G 3 C
Council of the European Union Brussels, 13 April 2016 (OR. en) 7800/16 RECH 92 TELECOM 43 NOTE From: To: Subject: Presidency Delegations Draft Council conclusions on the transition towards an Open Science
More informationAccess to re-usable public sector information: the European Data Portal and the CEF programme
Access to re-usable public sector information: the European Data Portal and the CEF programme Daniele Rizzi, European Commission - DG Connect, Unit Data Value Chain Open (public) data: Why does it matter
More informationE2ES to Accelerate Next-Generation Genome Analysis in Clinical Research
www.hcltech.com E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution
More informationIntroduction to ELIXIR Andy Smith, ELIXIR Hub 18 March 2015 Wageningen
Introduction to ELIXIR Andy Smith, ELIXIR Hub 18 March 2015 Wageningen European Life Sciences Infrastructure for Biological Information www.elixir europe.org ELIXIR connects national bioinformatics centres
More informationPersonalized. Health in Canada
Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute
More informationBiotechnology Activities at the National Institutes of Health: Priorities and Trends. US-EU Task Force on Biotechnology Brussels, July, 2006
Biotechnology Activities at the s of Health: Priorities and Trends US-EU Task Force on Biotechnology Brussels, July, 2006 s of Health Office of of the the Director on on Aging on on Alcohol Abuse and and
More informationGoverning Interinstitutional
Governing Interinstitutional Research John F. Steiner, MD, MPH Senior Director Institute for Health Research Kaiser Permanente Colorado Chairman, Kaiser Permanente National Research Council Governing Board
More informationELIXIR KPI framework and alignment of KPIs between e-infrastructures and research infrastructures
ELIXIR KPI framework and alignment of KPIs between e-infrastructures and research infrastructures Rafael C Jimenez, ELIXIR CTO June 8, 2017 e-irg workshop June 2017 www.elixir-europe.org ELIXIR European
More informationEU Big Data Initiatives
European Network of Excellence for Big Data in Hematology, consisting of 51 partners from 11 countries. Aliki Taylor, HARMONY Alliance Partner Director Global Health Outcomes, Takeda EU Big Data Initiatives
More informationPopulation Genetics & Drug Discovery
Population Genetics & Drug Discovery examples from Finland Mark J. Daly Chief, Analytic and Translational Genetics Unit Massachusetts General Hospital Co-director, Medical and Population Genetics Broad
More informationThe 100,000 Genomes Project Genomics Collaboration Event Finnish Residence
The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary
More informationVirtual Physiological Human: From Global Vision to Clinical Practice
Virtual Physiological Human: From Global Vision to Clinical Practice Karl A. Stroetmann & Marco Viceconti empirica, Bonn, Germany & Istituto Ortopedico Rizzoli, Bologna Italy with Rainer Thiel, empirica
More informationMaximising the value of research data: Wellcome Trust perspective
Maximising the value of research data: Wellcome Trust perspective University of Cambridge 22 January 2016 David Carr Wellcome Trust d.carr@wellcome.ac.uk Slides made available under http://creativecommons.org/licenses/by/4.0/
More informationIntroduc)on to Databases and Resources Biological Databases and Resources
Introduc)on to Bioinforma)cs Online Course : IBT Introduc)on to Databases and Resources Biological Databases and Resources Learning Objec)ves Introduc)on to Databases and Resources - Understand how bioinforma)cs
More informationVision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University
Vision, aims and strategies Department of Immunology, Genetics and Pathology Uppsala University April19,2011 SCOPEOFACTIVITIESATIGP Research at the Department focuses on translational medicine through
More informationNetwork-centric Biomedicine: re-engineering the Knowledge Enterprise
Network-centric Biomedicine: re-engineering the Knowledge Enterprise Ken Buetow, Ph.D. Director Computational Science and Informatics Core Program, Complex Adaptive Systems Initiative Arizona State University
More informationTHE CONVERGENCE INITIATIVE TO MAXIMISE THE VALUE FROM EUROPEAN RESEARCH
THE CONVERGENCE INITIATIVE TO MAXIMISE THE VALUE FROM EUROPEAN RESEARCH Georges De Moor EuroRec, Ghent University Electronic Health Records for Clinical Research 192 Growing number of Participating Projects
More informationBiomarkers as an emerging growth area in Denmark
Biomarkers as an emerging growth area in Denmark International Conference on Perspectives in Precision Medicine, Copenhagen March 1, 2018 Kim Holmstrøm, PhD. Chairman of The Danish Biomarker Network R&D
More informationLIAISON ALLOY HEALTH PLATFORM
PRODUCT OVERVIEW LIAISON ALLOY HEALTH PLATFORM WELCOME TO YOUR DATA-INSPIRED FUTURE THE LIAISON ALLOY HEALTH PLATFORM Healthcare and life sciences organizations are struggling to deal with unprecedented
More informationCAN GDPR WORK FOR HEALTH SCIENTIFIC RESEARCH? BRUSSELS OCTOBER 22 ND CIPL EFPIA FPF EXECUTIVE SUMMARY
CAN GDPR WORK FOR HEALTH SCIENTIFIC RESEARCH? BRUSSELS OCTOBER 22 ND 2018 - CIPL EFPIA FPF EXECUTIVE SUMMARY Despite many actors good intentions, the health research sector has so far survived GDPR rather
More informationNew WHO Report: Access to new medicines in Europe: Technical review of policy initiatives and opportunities for collaboration and research
New WHO Report: Access to new medicines in Europe: Technical review of policy initiatives and opportunities for collaboration and research Hanne Bak Pedersen Programme Manager Health Technologies and Pharmaceuticals
More informationGene therapy. Findings by Alert
Gene therapy Published Mar 21, 2000 Version 1 Findings by Alert Research in gene therapy has increased dramatically during the past 15 years, particularly in the United States. The research has encompassed
More informationAccess to Information from Molecular Biology and Genome Research
Future Needs for Research Infrastructures in Biomedical Sciences Access to Information from Molecular Biology and Genome Research DG Research: Brussels March 2005 User Community for this information is
More informationYour genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health
Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, 2018 Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Overview Inova s Precision Medicine Journey MediMap
More informationAll of Us Research Program
All of Us Research Program National Minority Quality Forum Stephanie Devaney, PhD Deputy Director, All of Us Research Program June 21, 2018 #joinallofus All of Us Mission and Objectives Nurture relationships
More informationOverview of Health Informatics. ITI BMI-Dept
Overview of Health Informatics ITI BMI-Dept Fellowship Week 5 Overview of Health Informatics ITI, BMI-Dept Day 10 7/5/2010 2 Agenda 1-Bioinformatics Definitions 2-System Biology 3-Bioinformatics vs Computational
More informationQ4. WORK STREAMS Discovery, Cloud, Large Scale Genomics. DRIVER PROJECTS ELIXIR Beacon, EVA/EGA/ENA. WORK STREAMS Discovery
2018 - Q4 Search The GA4GH Search API enables a search engine for genomic and clinical data by providing specification for query language across genomic, phenotypic, and clinical data that can be used
More informationGMI: Global Microbial Identifier
GMI: Global Microbial Identifier The future of microbiology: Identification and Surveillance will merge through the use of Whole Genome Sequencing (WGS) Jørgen Schlundt Professor Technical University of
More informationWelcome to the Ministry of Foreign Affairs
Welcome to the Ministry of Foreign Affairs indk@um.dk www.investindk.com National Experimental Therapy Partnership (NEXT) NEXT is a public-private partnership within clinical research offering a one stop
More informationGenetics and Bioinformatics
Genetics and Bioinformatics Kristel Van Steen, PhD 2 Montefiore Institute - Systems and Modeling GIGA - Bioinformatics ULg kristel.vansteen@ulg.ac.be Lecture 1: Setting the pace 1 Bioinformatics what s
More informationBridging the Gap Between Basic and Clinical Research. Julio E. Celis Danish Cancer Society
Bridging the Gap Between Basic and Clinical Research Julio E. Celis Danish Cancer Society Barriers and Oportunities in Translational Research Promise of the new technologies What is Europe doing? Challenges
More informationBiomedical Informatics in BIG DATA Era
Biomedical Informatics in BIG DATA Era Yang C. Fann, Ph.D. Director, Intramural IT and Bioinformatics Program National Institute of Neurological Disorders and Stroke Disclaimer The opinions or assertions
More informationROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure
ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure Marialuisa Lavitrano Università Milano-Bicocca Coordinatore BBMRI-Italia
More informationHuman Microbiome Project: A Community Resource. Lita M. Proctor, Ph.D. Coordinator, Human Microbiome Project NHGRI/NIH
Human Microbiome Project: A Community Resource Lita M. Proctor, Ph.D. Coordinator, Human Microbiome Project NHGRI/NIH 2016 HIV Microbiome Workshop November 17, 2016 1 Human Microbiome Project: 2007 to
More informationWhole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015
Whole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015 Dr. I.J. Nijman Disclosure slide (Potential) conflict of interest None For this meeting relevant
More informationPrecision Medicine. Presented by:
Precision Medicine Presented by: Prepared Brendan FitzGerald For: Enabling better health through information technology. Healthcare Information and Management Systems Society (HIMSS) HIMSS is a global,
More informationPolo Bibliotecario di Scienze, Farmacologia e Scienze Farmaceutiche. Scuola di Dottorato di Ricerca in Scienze Molecolari
Polo Bibliotecario di Scienze, Farmacologia e Scienze Farmaceutiche Scuola di Dottorato di Ricerca in Scienze Molecolari Open research data Scuola di Dottorato di Ricerca in Scienze Molecolari Information
More informationMediSapiens Ltd. Because data is not knowledge. 4th of November Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd
4th of November 2014 MediSapiens Ltd Because data is not knowledge Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2014 MediSapiens Ltd. All rights reserved. medisapiens.com MediSapiens Brief
More informationChallenges during the development of ATMPs
Challenges during the development of ATMPs CAT-DGTI Workshop Dresden 11.9.2014 Paula Salmikangas CAT Chair An agency of the European Union Gene Therapy Medicinal Products Somatic Cell Therapy Medicinal
More informationThe International Consortium for Personalised Medicine
The International Consortium for Personalised Medicine Mairead O Driscoll Alliance for Biomedical Research in Europe, 8 November 2017 Personalised Medicine A definition Characterisation of individuals
More informationLinguamatics NLP for Electronic Health Records
1 Linguamatics 2013 Linguamatics NLP for Electronic Health Records 2 Linguamatics 2013 Click Agenda to to edit edit Master Master title style title style Linguamatics and I2E Overview Customer case studies
More informationFuture State Architecture Guide
Future State Architecture Guide Contents 1 System Architecture... 1 1.1 Modular CRVS Architecture... 1 1.2 Integrated CRVS Architecture... 2 1.3 Interoperable CRVS Architecture... 3 1.4 Strengths and Weaknesses
More informationSupplementary Materials for
www.sciencetranslationalmedicine.org/cgi/content/full/6/242/242cm6/dc1 Supplementary Materials for Sandbox: Building and Sharing Resources This PDF file includes: Mark David Lim E-mail: mlim@fastercures.org
More informationGenetic databases. Anna Sowińska-Seidler, MSc, PhD Department of Medical Genetics
Genetic databases Anna Sowińska-Seidler, MSc, PhD seidler@ump.edu.pl Department of Medical Genetics Genetic databases what to start with? www.ncbi.nml.nih.gov NCBI National Center for Biotechnology Information
More informationNIH Institutes and Areas of SBIR Research: (shown in order of FY 2010 Funding amounts)
NIH Institutes and Areas of SBIR Research: (shown in order of FY 2010 Funding amounts) 1. NCI (National Cancer Institute) cancer cause, prevention, detection, diagnosis, treatment and control 2. NIAID
More informationBCNet Catalogue Dictionary_v1-1.xlsx 04/12/ :39
The information about Biobank is organized in three different sections: General Information, Services, and Members. Creating a biobank in the system creates its General Information part. General Information
More informationClinical studies. BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE
Clinical studies BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE www.imbm.sk barboravlk@gmail.com Biomedical research 1. Basic research a. In vitro = cell cultures b. In vivo = experimental animals c.
More informationLessons learned from Nordic research collaboration The Nordic colon cancer project. Joakim Dillner Director, BBMRI.se (Sweden)
Lessons learned from Nordic research collaboration The Nordic colon cancer project Joakim Dillner Director, BBMRI.se (Sweden) What is the Nordic advantage, really? -Possibility to link biobanks to nationwide,
More informationTowards a P4 Healthcare System: Predictive, Preventive, Personalized & Participatory
Towards a P4 Healthcare System: Predictive, Preventive, Personalized & Participatory Bull, 2012 Natalia Jiménez Lozano Business Development Manager BULL e-health Consultancy & Business Solutions Tlf: 913939253
More informationChallenges of Personalized Health for Clinical Medicine. Peter J Meier-Abt Swiss Academy of Medical Sciences (SAMS) Berne, Switzerland
Challenges of Personalized Health for Clinical Medicine Peter J Meier-Abt Swiss Academy of Medical Sciences (SAMS) Berne, Switzerland Personalisierte Medizin Personalisierte Gesundheit Personalisierte
More information- OMICS IN PERSONALISED MEDICINE
SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary
More informationAmendment of the Work Programme 2017 version 1
AMENDMENT OF THE CORE WORK PROGRAMME 2017 Version 1.1 Prepared for the consideration of the AoM#9 11 April 2017 1 This document is concerned with amendments to the Core Work Programme 2017. It contains
More informationThat ll be the day. From Trends to Scenarios to Strategy Example from health care / Martin Kruse. Agenda
Copenhagen Institute for Futures Studies International independent non-profit organization with 45 years of experience as strategic advisors Members From Trends to Scenarios to Strategy Example from health
More informationNorwegian experience with meeting public sector requirements
Norwegian experience with meeting public sector requirements SEMIC.EU Methodology workshop Brüssels 2 february 2009 Mona Naomi Lintvedt, senior adviser Agency for Public Management and egovernment In Norwegian:
More informationPharmacogenetics of Drug-Induced Side Effects
Pharmacogenetics of Drug-Induced Side Effects Hui - Ching Huang Department of Pharmacy, Yuli Hospital DOH Department of Pharmacology, Tzu Chi University April 20, 2013 Brief history of HGP 1953: DNA
More informationPromoting Free Flow of Health Data. Peter Walgemoed, Carelliance
Promoting Free Flow of Health Peter Walgemoed, Carelliance curation with (EU) Citizen design. Paper 2016 2 Health Eco-system stakeholders Health Client Shared Personal Case Decision Making to Improve Quality
More informationTEXT MINING: THE NEXT DATA FRONTIER
TEXT MINING: THE NEXT DATA FRONTIER An infrastructural approach for mining scientific content Natalia Manola Athena Research & Innovation Center OpenMinTeD OUTLINE Text mining on scientific content What
More informationHow European RIs can boost Open Science & Open Innovation
How European RIs can boost Open Science & Open Innovation Kurt Zatloukal, Medical University Graz, Austria Corbel Innovation Meeting Brussels, June 20th, 2017 Grant agreement No 654248 Funded by GZ 10.470/0016-II/3/2013
More information